Octave Announces Publication of Analytical Validation Study Results in Nature Communications More

Recent Announcements & Press

Personalized Approach to Measuring and Managing MS and Other Neurodegenerative Diseases with Bill Hagstrom Octave Bioscience

Octave Welcomes Maital Shemesh-Rasmussen as Chief Commercial Officer

Octave Bioscience Announces $32 Million Series B Financing

Octave Note

Media Library